2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow SmithKline Beecham: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT) Insulin, Glimepiride, Rosiglitazone - Type 2 Diabetes Mellitus | Phase 3 | Completed | VA Office of Research and Development | 1791 | 2000-12-01 | 2017-03-30 |
| A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis Albendazole - Protozoan Infections, HIV Infections | Phase 3 | Completed | SmithKline Beecham | 2005-06-24 |
AIDS-Related Opportunistic Infections (1) · Diabetes Mellitus, Type 2 (1) · HIV Infections (1) · Insulin Resistance (1) · Intestinal Diseases (1) · Protozoan Infections (1)
Albendazole (1) · Insulin (1) · Metformin (1) · Rosiglitazone (1) · glimepiride (1)
United States (2) · Puerto Rico (1)
Carlos Abraira, MD (1) · William Duckworth, MD (1)
PMID 11347758, PMID 14583175, PMID 16043738, PMID 16504835, PMID 16627388, PMID 16784922, PMID 18406632, PMID 18671796, PMID 19092145, PMID 19655124, PMID 19720420, PMID 19726779, PMID 19898642, PMID 20807873, PMID 21059830, PMID 21775749, PMID 23536583, PMID 25048382, PMID 25456099, PMID 26039600, PMID 26786575, PMID 27006510, PMID 30455335, PMID 31167051, PMID 33367811